# Title

 Food and Drugs. PART 208â€”MEDICATION GUIDES FOR PRESCRIPTION DRUG PRODUCTS


# ID

 CFR-2018-title21-vol4.Pt. 208


# Structured Analysis Summary

| Type        | Values                                                            |
|:------------|:------------------------------------------------------------------|
| Constraints | ['within', 'no less than', 'before', 'after']                     |
| Condition   | ['subject to', 'where', 'not subject to', 'when', 'unless', 'if'] |
| Entities    | ['Food', 'English', 'Scope', 'Serious']                           |


# Structured Analysis With Context

 


## Constraints

| Constraints   | Context                                                                                                    |
|:--------------|:-----------------------------------------------------------------------------------------------------------|
| within        | this part, drug product also means biological product within the meaning of section 351(a) of the Public   |
| no less than  | Guide.&#8221; The established or proper name shall be no less than  one-half the height of the brand name. |
| after         | recent revision of the Medication Guide placed immediately after  the last section.                        |
| before        | shall obtain FDA approval of the Medication Guide before  the Medication Guide may be distributed.         |


## Condition

| Condition      | Context                                                                                                               |
|:---------------|:----------------------------------------------------------------------------------------------------------------------|
| when           | required under this part is to provide information when the FDA determines in writing that it is                      |
| if             | (c) Patient labeling will be required  if the FDA determines that one or more of                                      |
| if             | Each heading shall contain the spec if ic information as follows: (1) The brand name                                  |
| unless         | The Medication Guide may not identify an indication  unless the indication is identified in the indications and       |
| if             | Guide shall contain directions regarding what to do if any of the contraindications apply to a patient,               |
| if             | the importance of adhering to the dosing instructions, if this is particularly important; (ii) A statement describing |
| if             | the importance of adhering to the dosing instructions, if this is particularly important; (ii) A statement describing |
| if             | the importance of adhering to the dosing instructions, if this is particularly important; (ii) A statement describing |
| where          | taking a scheduled dose(s) of the drug product, where  there are data to support the advice, and                      |
| where          | taking a scheduled dose(s) of the drug product, where  there are data to support the advice, and                      |
| when           | as tobacco or alcohol) that patients should avoid when using the medication; (ii) A statement of the                  |
| if             | followed by a statement or statements of spec if ic, important precautions patients should take to ensure             |
| if             | followed by a statement or statements of spec if ic, important precautions patients should take to ensure             |
| if             | followed by a statement or statements of spec if ic, important precautions patients should take to ensure             |
| if             | followed by a statement or statements of spec if ic, important precautions patients should take to ensure             |
| if             | (vi) A statement of special precautions,  if any, that apply to the safe and effective                                |
| if             | (ii) A statement of the risk,  if there is one, of patients' developing dependence on                                 |
| if             | subheadings may be interspersed throughout the Medication Guide, if  appropriate.                                     |
| where          | (d) The label of each container or package,  where the container label is too small, of drug                          |
| when           | Medication Guide is required under this part shall, when the product is dispensed to a patient (or                    |
| unless         | to each patient (or to the patient's agent) unless  an exemption applies under &#167;&#8201;208.26.                   |
| not subject to | (f) An authorized dispenser or wholesaler is  not subject to section 510 of the Federal Food, Drug, and               |
| if             | to receive a Medication Guide because of sign if icant concerns about the effect of a Medication                      |
| subject to     | the licensed practitioner who prescribes a drug product subject to this part determines that it is not in             |
| subject to     | the authorized dispenser of a prescription drug product subject to this part shall provide a Medication Guide to      |
| when           | Medication Guide to any patient who requests information when the drug product is dispensed regardless of any         |


## Entities

| Entities   | Context                                                                                                        |
|:-----------|:---------------------------------------------------------------------------------------------------------------|
| Food       | Food  and Drugs.                                                                                               |
| Scope      | Scope  and purpose.                                                                                            |
| Serious    | (k)  Serious risk or serious adverse effect means an adverse                                                   |
| English    | (1) The Medication Guide shall be written in English , in nontechnical, understandable language, and shall not |
| Food       | Food and Drug Administration&#8221; shall appear at the bottom                                                 |


